Research is the foundation of all we do at Chiron. Through cutting-edge clinical trials, scientific research, and novel treatments, we are dedicated to improving our knowledge of and ability to treat cancer. In addition to improving patient outcomes now, we want to set the stage for cancer care in the future.
By using the immune system to combat cancer cells, immunotherapy is transforming the way we treat the disease. In order to provide patients with more efficient and individualized treatment options, our immunotherapy research focuses on creating novel immune-based therapies, such as checkpoint inhibitors, cancer vaccines, and CAR T-cell therapy.
Customizing treatment according to the unique genetic composition of each patient’s cancer is known as precision medicine. In order to create medicines that specifically target those signs and enhance patient outcomes, our research in targeted therapeutics focuses on discovering certain genetic abnormalities and molecular markers that propel the growth of cancer.
We are researching the genetic alterations and mutations that cause cancer using cutting-edge genomic methods and molecular profiling. We can create more precise diagnostic methods and treatments, such as individualized treatment programs that take into account the particulars of each patient’s cancer, by comprehending these genetic changes.
The key to bettering the results of cancer treatment is early detection. As part of our research, we are developing non-invasive diagnostic methods, such liquid biopsies and sophisticated imaging techniques, to identify cancer early on, when it is most amenable to treatment. We want early cancer detection to become a reality for everyone by increasing diagnostic accessibility and accuracy.
Accurate diagnosis are vital for successful cancer treatment. If you have concerns or symptoms that may indicate cancer, don’t wait. Contact us today to schedule a diagnostic evaluation
